Axalta Coating Systems Ltd.AXTA

Axalta Coating Systems Ltd. filed a 10-Q for the quarter ended 31 March 2026 showing $1.25bn of revenue, $90m net income, and $608m of cash on hand, but the inventory line tells the more interesting story: $770m of coatings sitting in warehouses, up $20m from the prior quarter. Operating income clocked in at $146m and diluted EPS landed at $0.42 on 214.6m shares, which means the company is still generating cash but not yet printing it at the speed that might justify the board’s merger ambitions with AkzoNobel.

Axalta makes liquid and powder coatings for industrial, automotive, and decorative end markets, and the business is split across Performance Coatings and Powder Coatings. The Powder Coatings segment grew organic sales 7% in the first half of 2026, while Performance Coatings organic sales were flat and Decorative Paints shrank 4%, leaving total organic sales up just 2% year-over-year. The company’s “other” category in the revenue bridge contains hyperinflation adjustments, which is accountant-speak for “FX and weird stuff we’ll explain later,” so the headline growth is not as crisp as the investor deck pretends.

The company’s most recent 10-Q records $7.56bn of assets against $5.09bn of liabilities, leaving stockholders’ equity at $2.42bn. Net cash from operating activities was $68m in the quarter, capex was $50m, and R&D spend was a modest $18m. The board’s proposed merger with AkzoNobel is framed as a merger of equals, but the joint press release is careful to state that no securities are being offered and no shareholder should act until the definitive proxy lands. Translation: the romance is real, the filing trail is not.

For a closer look at the industrial coatings business, consult Axalta’s investor materials and the Powder Coatings segment growth, which is the one bright spot in an otherwise flat revenue bridge. The merger narrative is compelling, but the balance sheet remains the honest ledger: $770m of inventory, $608m of cash, and a liabilities-to-equity ratio that asks whether the deal is growth or rescue. The definitive proxy will clarify the terms, the synergies, and the path to EPS accretion; until then, the filings read like a pre-nup where the vows are still being written.

Axalta’s SEC EDGAR index lists all recent filings, including the 425s outlining the proposed merger, the DEFA14A summarising segment performance, and the 10-Q disclosing the cash, profit, and inventory numbers above. The company’s submissions JSON and companyfacts JSON provide structured data for those who prefer JSON to human prose.

What changed this week: Axalta filed a 425 on 23 July 2026 updating the proposed merger with AkzoNobel, and a DEFA14A on 22 July 2026 detailing organic sales growth by segment. The prior week saw additional 425s filed on 13 July 2026 and 8 July 2026, each restating the strategic rationale and reminding readers that no securities are being offered until the definitive materials are published. The company’s SEC filings remain the primary source for facts; no analyst valuation commentary or market rumours are supplied in the evidence.